As of February 2023 Orchard Therapeutics has a market cap of $68.41 Million. This makes Orchard Therapeutics the world's 6749th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $68.41 M | 45.55% |
2022 | $47 M | -71.63% |
2021 | $0.16 B | -60.98% |
2020 | $0.42 B | -68.14% |
2019 | $1.33 B | -1.33% |
2018 | $1.35 B |
On Feb 6th, 2023 the market cap of Orchard Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | $14.37 M | -78.99% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | $68.41 M | 0.00% | ๐ฌ๐ง UK |
![]() Novavax NVAX | $0.94 B | 1,277.95% | ๐บ๐ธ USA |
![]() Novocure
NVCR | $9.64 B | 13,996.61% | Jersey |